BEIJING: The battlefield of a global vaccine race has seemingly transferred from research and development to the market after Russia announced its approval of the world’s first coronavirus disease 2019 (Covid-19) vaccine on Tuesday, soon after which the United States announced to purchase another 100 million doses of a domestic candidate, revealing the Trump administration’s anxiety over Russia’s move.
Chinese experts predicted that the move would be a big leap indicating that humans are moving from research and development (R&D) on a Covid-19 vaccine to the market, which would encourage more nations to accelerate their pace while the pandemic has not yet been brought under control globally.
Already have an active account? Log in here.
Continue reading with one of these options:
Continue reading with one of these options:
Premium + Digital Edition
Ad-free access
P 80 per month
(billed annually at P 960)
- Unlimited ad-free access to website articles
- Limited offer: Subscribe today and get digital edition access for free (accessible with up to 3 devices)
TRY FREE FOR 14 DAYS
See details
See details
If you have an active account, log in
here
.